Companies House · 00119006

NOVARTIS PHARMACEUTICALS UK LIMITED

UK registered company, private limited company, incorporated 8 Dec 1911.

Active
50
Public contracts
158
Spend payments
£2.5m
Total spend

NOVARTIS PHARMACEUTICALS UK LIMITED is a UK company registered at Companies House under number 00119006. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
00119006
Status
Active
Company type
Private Limited Company
Incorporated
8 Dec 1911
Country of origin
United Kingdom
Registered office
2ND FLOOR, THE WESTWORKS BUILDING WHITE CITY PLACE, LONDON, W12 7FQ, UNITED KINGDOM
Nature of business (SIC)
21100 - Manufacture of basic pharmaceutical products
Accounts category
FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to NOVARTIS PHARMACEUTICALS UK LIMITED.

ProcurementBuyerAwardedValue
NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024NHS England
NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024NHS England
NHS National Generic Pharmaceuticals Wave 15aNHS England
NHS National Proprietary Category Tender - 1 May 2024NHS England
NHS National Proprietary Category Tender - 1 May 2024NHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS Framework Agreement for Branded Medicines – NationalNHS England
NHS National Pharmaceuticals — Fulvestrant, Darunavir and ImatinibThe NHS Commissioning Board (operating under the name of NHS England)
NHS Framework, North of England, Branded Medicines - Tranche A and Annual TrancheThe NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.The NHS Commissioning Board (operating under the name of NHS England)
Proprietary DrugsVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)
NHS Framework Agreement for the supply of Medical Retinal Vascular TreatmentsNHS England
Procurement of Trametinib 30 tablet packBELFAST HEALTH AND SOCIAL CARE TRUST
SIPONIMOD 2 mg Tablets 28 Tablet PackBELFAST HEALTH AND SOCIAL CARE TRUST
Midostaurin Capsules (PAS)BELFAST HEALTH AND SOCIAL CARE TRUST
SECUKINUMAB 300 mg Pre-filled Injection 1 Pen PackBELFAST HEALTH AND SOCIAL CARE TRUST
Contract for MIDOSTAURIN (RYDAPT) 25 mg CapsulesNorthern Health and Social Care Trust
ZOLGENSMA 2 X 10 EXP 13 VECTOR GENOMES/ML Solution for Infusion 1 Treatment Pack PackBELFAST HEALTH AND SOCIAL CARE TRUST
ASCIMINIB 40MG TAB 60PACKBELFAST HEALTH AND SOCIAL CARE TRUST
Medicinal Products Dynamic Purchasing System (131864)Procurement & Logistics Service
SIPONIMOD 2 mg Tablets 28 Tablet PackBELFAST HEALTH AND SOCIAL CARE TRUST
NOVARTIS PHARMACEUTICALS UK LTD (WT) - WT2024-11, WT2024-12, WT2024-13 - RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjectionsWestern Health and Social Care Trust
Contract for ASCIMINIB 40mg tabletsNorthern Health and Social Care Trust
RIBOCICLIB 200 mg Tablets 63 Tablet PackBELFAST HEALTH AND SOCIAL CARE TRUST
SECUKINUMAB 300 mg Pre-filled Injection 1 Pen PackBELFAST HEALTH AND SOCIAL CARE TRUST
Procurement of Midostaurin from Novartis UKBELFAST HEALTH AND SOCIAL CARE TRUST
NP33923 RanibizumabThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Interferon Beta-1b (Extavia®)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Oncology Generic Medicines - AdditionsThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Oncology Generics MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Oncology Generics MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Oncology Generics MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024NHS England
Procurement of Trametinib (Mekinist)BELFAST HEALTH AND SOCIAL CARE TRUST
NETSPOT DOTATATECAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
Proprietary DrugseTenderwales
Generic Drugs - Tablets & CapsulesVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services ( on behalf of All LHB's and Trusts )
Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025NHS England
Interferon Beta-1b (Extavia®)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
NHS National Framework Agreement for OmalizumabNHS England
Medicinal Products Dynamic Purchasing System (131864)Regional Business Services Organisation, Procurement and Logistics Service
Interferon Beta-1b (Extavia®)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
NP33922 RanibizumabThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
CanakinumabNorthern Health And Social Care Trust£120k
TRAMETINIB 2MG TABLETS, 30 tablet, pack, PACK OF 1Belfast Health and Social Care Trust (BHSCT)4 May 2026£270k
NHS National Framework Agreement for OmalizumabNHS England26 Nov 2025£87.4m
SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for InjectionWestern Health & Social Care Trust10 Nov 2025£4.6m

Supplier identities

How this company appears as a supplier across the data.

Recent transparency payments

158 payments recorded, totalling £2,491,213.

PayerDescriptionDateAmount
salisbury-nhs-foundation-trustDRUGS28 Dec 2018£4.8k
salisbury-nhs-foundation-trustDRUGS28 Dec 2018£24.1k
salisbury-nhs-foundation-trustDRUGS12 Jul 2018£5.3k
salisbury-nhs-foundation-trustDRUGS12 Jul 2018£26.7k
salisbury-nhs-foundation-trustDRUGS11 May 2018£4.5k
salisbury-nhs-foundation-trustDRUGS11 May 2018£22.3k
salisbury-nhs-foundation-trustDRUGS23 Feb 2018£22.3k
salisbury-nhs-foundation-trustDRUGS23 Feb 2018£4.5k
salisbury-nhs-foundation-trustDRUGS9 Feb 2018£5.3k
salisbury-nhs-foundation-trustDRUGS9 Feb 2018£26.7k
salisbury-nhs-foundation-trustDRUGS21 Dec 2017£26.7k
salisbury-nhs-foundation-trustDRUGS21 Dec 2017£4.8k
salisbury-nhs-foundation-trustDRUGS21 Dec 2017£5.3k
salisbury-nhs-foundation-trustDRUGS21 Dec 2017£24k
salisbury-nhs-foundation-trustDRUGS3 Aug 2017£4.2k
salisbury-nhs-foundation-trustDRUGS3 Aug 2017£21k
salisbury-nhs-foundation-trustDRUGS29 Jun 2017£5.4k
salisbury-nhs-foundation-trustDRUGS29 Jun 2017£27k
salisbury-nhs-foundation-trustDRUGS21 Apr 2016£4.5k
salisbury-nhs-foundation-trustDRUGS21 Apr 2016£22.7k
salisbury-nhs-foundation-trustDRUGS5 Feb 2016£23.2k
salisbury-nhs-foundation-trustDRUGS5 Feb 2016£4.6k
salisbury-nhs-foundation-trustDRUGS15 Jan 2016£4.5k
salisbury-nhs-foundation-trustDRUGS15 Jan 2016£4.5k
salisbury-nhs-foundation-trustDRUGS15 Jan 2016£22.3k

FAQs about NOVARTIS PHARMACEUTICALS UK LIMITED

Is NOVARTIS PHARMACEUTICALS UK LIMITED an active company?

NOVARTIS PHARMACEUTICALS UK LIMITED (company number 00119006) is recorded as "Active", incorporated on 8 Dec 1911.

What does NOVARTIS PHARMACEUTICALS UK LIMITED do?

Its Companies House nature-of-business (SIC) is: 21100 - Manufacture of basic pharmaceutical products.

Has NOVARTIS PHARMACEUTICALS UK LIMITED won UK public-sector contracts?

Yes — 50 public-sector contract awards are linked to this company in our data.

How much public money has NOVARTIS PHARMACEUTICALS UK LIMITED received?

158 transparency-spend payments totalling £2,491,213 are recorded against NOVARTIS PHARMACEUTICALS UK LIMITED.

Where is NOVARTIS PHARMACEUTICALS UK LIMITED based?

Its registered office is 2ND FLOOR, THE WESTWORKS BUILDING WHITE CITY PLACE, LONDON, W12 7FQ, UNITED KINGDOM.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable